TRUSAMIDE dorzolamide (as hydrochloride) 20 mg/mL eye drops bottle Australia - English - Department of Health (Therapeutic Goods Administration)

trusamide dorzolamide (as hydrochloride) 20 mg/ml eye drops bottle

viatris pty ltd - dorzolamide hydrochloride, quantity: 22.26 mg/ml (equivalent: dorzolamide, qty 20 mg/ml) - eye drops - excipient ingredients: water for injections; benzalkonium chloride; hyetellose; mannitol; sodium citrate dihydrate; sodium hydroxide - trusamide eye drops are indicated in the treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma.

DORZOLAMIDE HYDROCHLORIDE OPHTHALMIC SOLUTION 2%, 10ML OPHTHALMIC SOLUTION 2%, 10ML United States - English - NLM (National Library of Medicine)

dorzolamide hydrochloride ophthalmic solution 2%, 10ml ophthalmic solution 2%, 10ml

alvogen inc. - dorzolamide hydrochloride (unii: qzo5366ew7) (dorzolamide - unii:9jdx055tw1) - dorzolamide 22.3 mg in 1 ml

DORZOLAMIDE HYDROCHLORIDE-TIMOLOL MALEATE OPHTHALMIC SOLUTION STERILE OPHTHALMIC SOLUTION United States - English - NLM (National Library of Medicine)

dorzolamide hydrochloride-timolol maleate ophthalmic solution sterile ophthalmic solution

alvogen inc. - dorzolamide hydrochloride (unii: qzo5366ew7) (dorzolamide - unii:9jdx055tw1) - dorzolamide 22.3 mg in 1 ml

DORZOLAMIDE HCL AND TIMOLOL MALEATE hydrochloride solution United States - English - NLM (National Library of Medicine)

dorzolamide hcl and timolol maleate hydrochloride solution

actavis pharma, inc. - dorzolamide hydrochloride (unii: qzo5366ew7) (dorzolamide - unii:9jdx055tw1) - dorzolamide 20 mg in 1 ml

DORZOLAMIDE HCL hydrochloride solution United States - English - NLM (National Library of Medicine)

dorzolamide hcl hydrochloride solution

actavis pharma, inc. - dorzolamide hydrochloride (unii: qzo5366ew7) (dorzolamide - unii:9jdx055tw1) - dorzolamide 20 mg in 1 ml

DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE PRESERVATIVE FREE solution/ drops United States - English - NLM (National Library of Medicine)

dorzolamide hydrochloride and timolol maleate preservative free solution/ drops

aurobindo pharma limited - dorzolamide hydrochloride (unii: qzo5366ew7) (dorzolamide - unii:9jdx055tw1), timolol maleate (unii: p8y54f701r) (timolol anhydrous - unii:5jky92s7br) - dorzolamide hydrochloride and timolol maleate ophthalmic solution preservative free is indicated for the reduction of elevated intraocular pressure (iop) in patients with open-angle glaucoma or ocular hypertension who are insufficiently responsive to beta-blockers (failed to achieve target iop determined after multiple measurements over time). the iop-lowering of dorzolamide hydrochloride and timolol maleate ophthalmic solution administered twice a day was slightly less than that seen with the concomitant administration of 0.5% timolol administered twice a day and 2% dorzolamide administered three times a day [see clinical studies (14.1)]. dorzolamide hydrochloride and timolol maleate ophthalmic solution preservative free is contraindicated in patients with bronchial asthma, a history of bronchial asthma, or severe chronic obstructive pulmonary disease [see warnings and precautions (5.1)]. dorzolamide hydrochloride and timolol maleate ophthalmic solution preservative free is contraindicated in patients with s

DORZOLAMIDE HYDROCHLORIDE solution United States - English - NLM (National Library of Medicine)

dorzolamide hydrochloride solution

leading pharma, llc - dorzolamide hydrochloride (unii: qzo5366ew7) (dorzolamide - unii:9jdx055tw1) - dorzolamide hydrochloride ophthalmic solution is indicated in the treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma. dorzolamide hydrochloride ophthalmic solution is contraindicated in patients who are hypersensitive to any component of this product [see warnings and precautions (5.1) ]. teratogenic effects. developmental toxicity studies with dorzolamide hydrochloride in rabbits at oral doses of ≥ 2.5 mg/kg/day revealed malformations of the vertebral bodies. these malformations occurred at doses that caused metabolic acidosis with decreased body weight gain in dams and decreased fetal weights. no treatment-related malformations were seen at 1 mg/kg/day. these doses represent estimated plasma cmax levels in rabbits, 37 and 15 times higher than the lower limit of detection in human plasma following ocular administration, respectively. there are no adequate and well-controlled studies in pregnant women. dorzolamide hydrochloride ophthalmic solution should b